s6y
Company name or ticker
Search
Ben-Tzvi Avraham
3
TITAN PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
Filed
Tuesday, August 30, 2022
Period
Aug 15, 2022
Accession number
0001829126-22-016304
Documents
FORM 3
3
On sec.gov
Filing index
All files
Complete submission text
SGML header